Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from kura

Kura Oncology Q1 Earnings Call Highlights

Kura Oncology (NASDAQ:KURA) reported $5.8 million in first-quarter net product revenue from KOMZIFTI, its first commercial product, and said the launch is showing early signs of physician uptake, broad payer coverage and use in combination regimens, according to management’s earnings call for the fi

MarketBeat

1 Under-$10 Stock Set to Surge as Much as 850% in 2026

Kura is a classic high-risk, high-reward biotech investment that has entered a vital growth phase.

Barchart

Kura Oncology Scores $30 Million Boost As New Leukemia Drug Enters Major Trial

Kura Oncology, Inc. (NASDAQ:KURA) shares rose Friday after the biotechnology firm confirmed a $30 million milestone payment from its collaboration with Kyowa Kirin.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth

Investors are increasingly looking to biotechnology companies for potential breakthroughs and profitable returns, as the sector shows resilience and growth amid broader market volatility. Within this landscape, Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is capturing attention with its promising drug portfolio and financial performance.

Benzinga

Language is a ‘central element in being Māori’ – using structured literacy to teach te reo misses the point

Since the start of this year, all New Zealand schools have been required to use structured literacy to teach reading and writing – including the country’s 310 primary and intermediate Māori-medium kura (schools that teach in te reo Māori).

The Conversation

This IKEA hack turns the iconic KURA bed into the childhood den we all wanted - all you need is a sheet of MDF

The easy hack is perfect for the little one's in your life

Ideal Home

Biotech Buyers Beware: 3 Stocks to Avoid

The biotech industry is flourishing due to groundbreaking developments in cell and gene therapies and the rapid adoption of new technologies. However, not all biotech stocks are positioned to capitalize on the industry tailwinds. Thus, investors must beware of fundamentally weak stocks: Alpine Immune (ALPN), Kura Oncology (KURA), and Blueprint…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Buy, Hold, or Sell? Analyzing 3 Biotech Stocks Investors Are Watching

Amid the use of advanced technologies, personalized medicines, demand for quality treatments and therapies, and an aging population, the biotech industry appears to be on a steady path for expansion. Given this backdrop, let’s analyze the fundamentals of Biogen (BIIB), BioNTech (BNTX), and Kura (KURA) to determine which of these…

StockNews.com

Kura Oncology (KURA) Offers Speculators a Profit-Scalping Opportunity

With bullish traders anticipating a quick pop in KURA stock, outside observers need to pay attention, especially because of the underlying short position.

Barchart

Scottish Friendly outsources customer services

Jobs set to be created in Glasgow as new partnership signed

Insider UK

The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

People

Dipanjan BanchurSince

722 stories

Erica Stanford

18 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Ministry of Education

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.